Cargando…
Phenotypic analysis of images of zebrafish treated with Alzheimer's γ-secretase inhibitors
BACKGROUND: Several γ-secretase inhibitors (GSI) are in clinical trials for the treatment of Alzheimer's disease (AD). This enzyme mediates the proteolytic cleavage of amyloid precursor protein (APP) to generate amyloid β protein, Aβ, the pathogenic protein in AD. The γ-secretase also cleaves N...
Autores principales: | Arslanova, Dilyara, Yang, Ting, Xu, Xiaoyin, Wong, Stephen T, Augelli-Szafran, Corinne E, Xia, Weiming |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851663/ https://www.ncbi.nlm.nih.gov/pubmed/20307292 http://dx.doi.org/10.1186/1472-6750-10-24 |
Ejemplares similares
-
Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein
por: Yang, Ting, et al.
Publicado: (2008) -
γ-Secretase in Alzheimer’s disease
por: Hur, Ji-Yeun
Publicado: (2022) -
Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer’s Therapeutics
por: Mouchlis, Varnavas D., et al.
Publicado: (2020) -
The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
por: Chávez-Gutiérrez, Lucía, et al.
Publicado: (2012) -
Turning the tide on Alzheimer’s disease: modulation of γ-secretase
por: Luo, Joanna E., et al.
Publicado: (2022)